The Apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans

Journal of the American Society of Nephrology

Volumn 21, Issue 9, 2010, Pages 1422-1426

  Freedman, Barry I ^a   Kopp, Jeffrey B ^b   Langefeld, Carl D ^a   Genovese, Giulio ^c   Friedman, David J ^c   Nelson, George W ^e   Winkler, Cheryl A ^d   Bowden, Donald W ^a   Pollak, Martin R ^c,f  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN L1; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 9; UNCLASSIFIED DRUG; APOL1 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN; MOLECULAR MOTOR; MYH9 PROTEIN, HUMAN;

AFRICAN AMERICAN; AFRICAN TRYPANOSOMIASIS; APOL1 GENE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GLOMERULOSCLEROSIS; KIDNEY DISEASE; MYH9 GENE; NEPHROTIC SYNDROME; NOTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRYPANOSOMIASIS; ANIMAL; GENETICS; HUMAN; KIDNEY DISEASES; RISK; TRYPANOSOMIASIS, AFRICAN;

AFRICAN AMERICANS; ANIMALS; APOLIPOPROTEINS; HUMANS; KIDNEY DISEASES; LIPOPROTEINS, HDL; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TRYPANOSOMIASIS, AFRICAN;

EID: 77956535289     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010070730     Document Type: Note

References (18)

1. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175-1184, 2008
2. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS: MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40: 1185-1192, 2008
3. Freedman BI, Hicks PJ, Bostrom MA, Cunningham ME, Liu Y, Divers J, Kopp JB, Winkler CA, Nelson GW, Langefeld CD, Bowden DW: Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 75: 736-745, 2009
4. Freedman BI, Sedor JR: Hypertension-associated kidney disease: Perhaps no more. J Am Soc Nephrol 19: 2047-2051, 2008
5. Smith MW, Patterson N, Lautenberger JA, Truelove AL, McDonald GJ, Waliszewska A, Kessing BD, Malasky MJ, Scafe C, Le E, De Jager PL, Mignault AA, Yi Z, De The G, Essex M, Sankale JL, Moore JH, Poku K, Phair JP, Goedert JJ, Vlahov D, Williams SM, Tishkoff SA, Winkler CA, De La Vega FM, Woodage T, Sninsky JJ, Hafler DA, Altshuler D, Gilbert DA, O'Brien SJ, Reich D: A high-density admixture map for disease gene discovery in African Americans. Am J Hum Genet 74: 1001-1013, 2004
6. Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo NC, Ghiggeri GM, Ravazzolo R, Savino M, Del Vecchio M, d'Apolito M, Iolascon A, Zelante LL, Savoia A, Balduini CL, Noris P, Magrini U, Belletti S, Heath KE, Babcock M, Glucksman MJ, Aliprandis E, Bizzaro N, Desnick RJ, Martignetti JA: Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May- Heggllin/Fechtner Syndrome Consortium. Nat Genet 26: 103-105, 2000
7. Lipkowitz MS, Iyengar S, Molineros J, Langefeld CD, Comeau ME, Klotman PE, Bowden DW, Freedman RG, Khitrov G, Zhang W, Kao WH, Parekh RS, Choi M, Kopp JB, Winkler CA, Nelson G, Freedman BI, Bottinger EP, AASK Investigators: Association analysis of the non-muscle myosin heavy chain 9 gene (MYH9) in hypertensive nephropathy: African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol 20: 56A, 2009
8. Nelson GW, Freedman BI, Bowden DW, Langefeld CD, An P, Hicks PJ, Bostrom MA, Johnson RC, Kopp JB, Winkler CA: Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum Mol Genet 19: 1805-1815, 2010
9. Oleksyk TK, Nelson GW, An P, Kopp JB, Winkler CA: Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: Evidence of historical selection in Africa. PLoS ONE 5: e11474, 2010
10. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk T, Knob AU, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African-Americans. Science July 15, 2010 [epub ahead of print]
11. Vanhollebeke B, Pays E: The function of apolipoproteins L. Cell Mol Life Sci 63: 1937-1944, 2006
12. Bostrom MA, Freedman BI: The spectrum of MYH9-associated nephropathy. Clin J Am Soc Nephrol 5: 1107-1113, 2010
13. Williams TN: Human red blood cell polymorphisms and malaria. Curr Opin Microbiol 9: 388-394, 2006 (Pubitemid 44108720)
14. Derebail VK, Nachman PH, Key NS, Ansede H, Falk RJ, Kshirsagar AV: High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol 21: 413-417, 2010
15. Monajemi H, Fontijin RD, Pannekoek H, Horrevoets AJ: The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics 79: 539-546, 2002 (Pubitemid 34274295)
16. Wan G, Zhaorigetu S, Liu Z, Kaini R, Jiang Z, Hu CA: Apolipoprotein L1, a novel Bcl-2 homology domain 3 only lipid-binding protein, induces autophagic cell death. J Biol Chem 283: 21540-21549, 2008
17. Hartleben B, Godel M, Meyer-Schwesinger C, Liu S, Ulrich T, Kobler S, Wiech T, Grahammer F, Arnold SJ, Lindenmeyer MT, Cohen CD, Pavenstadt H, Kerjaschki D, Mizushima N, Shaw AS, Waiz G, Huber TB: Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120: 1084-1096, 2010
18. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N, Wasser WG, Behar DM, Skorecki K: Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Human Genet July 16, 2010 [epub ahead of print]